Antigen-specific T regulatory-1 cells are associated with immunosuppression in a chronic helminth infection (onchocerciasis)

Microbes and Infection

Volumn 4, Issue 13, 2002, Pages 1291-1300

  Satoguina, Judith ^a   Mempel, Martin ^b   Larbi, John ^a,c   Badusche, Marlis ^a   Löliger, Cornelius ^d   Adjei, Ohene ^c   Gachelin, Gabriel ^b   Fleischer, Bernhard ^a   Hoerauf, Achim ^a  

^a BERNHARD NOCHT INSTITUTE FOR TROPICAL MEDICINE   (Germany)

^b INSTITUT PASTEUR   (France)

^c KUMASI CENTRE FOR COLLABORATIVE RESEARCH IN TROPICAL MEDICINE   (Ghana)

^d UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

Helminth parasites; Human; T lymphocytes; Tolerance suppression; Tr1 cells

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 5;

ALLERGIC REACTION; ALLOIMMUNITY; ANTIGEN SPECIFICITY; ARTICLE; CELL STIMULATION; CYTOKINE PRODUCTION; DERMATITIS; HUMAN; HUMAN CELL; IMMUNOSUPPRESSIVE TREATMENT; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATION; NONHUMAN; ONCHOCERCIASIS; PRIORITY JOURNAL; T LYMPHOCYTE; TH1 CELL; TH2 CELL;

ANIMALS; ANTIGENS, CD; ANTIGENS, CD4; ANTIGENS, DIFFERENTIATION; ANTIGENS, HELMINTH; CD4-POSITIVE T-LYMPHOCYTES; CELLS, CULTURED; CHRONIC DISEASE; CLONE CELLS; CYTOKINES; HUMANS; IMMUNE TOLERANCE; IMMUNOCONJUGATES; IMMUNOSUPPRESSION; INTERFERON TYPE II; INTERLEUKIN-10; INTERLEUKIN-13; INTERLEUKIN-2; INTERLEUKIN-5; ONCHOCERCA VOLVULUS; ONCHOCERCIASIS;

VERMES;

EID: 0036848913     PISSN: 12864579     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1286-4579(02)00014-X     Document Type: Article

References (53)

1. Richards F., Hopkins D., Cupp E. Programmatic goals and approaches to onchocerciasis. Lancet. 355:2000;1663-1664.
2. Duke B.O.L. The population dynamics of Onchocerca volvulus in the human host. Trop. Med. Parasitol. 44:1993;61-68.
3. J.E. McMahon, P.E. Simonsen, Filariases, in: G.C. Cook (Ed.), Manson's Tropical Diseases, 20 ed, W.B. Saunders, London, 1996, pp. 1321-1368.
4. Darge K., Lucius R., Monson M.H., Behrendsen J., Büttner D.W. Immunohistological and electron microscopic studies of microfilariae in skin and lymph nodes from onchocerciasis patients after ivermectin treatment. Trop. Med. Parasitol. 42:1991;361-367.
5. Ottesen E.A. Immune responsiveness and the pathogenesis of human onchocerciasis. J. Infect. Dis. 171:1995;659-671.
6. Hoerauf A., Brattig N. Resistance and susceptibility in human onchocerciasis -beyond Th1 vs. Th2. Trends Parasitol. 18:2002;25-31.
7. Soboslay P.T., Dreweck C.M., Taylor H.R., Brotman B., Wenk P., Greene B.M. Experimental onchocerciasis in chimpanzees. Cell-mediated immune responses, and production and effects of IL-1 and IL-2 with Onchocerca volvulus infection. J. Immunol. 147:1991;346-353.
8. Hoffmann W.H., Pfaff A.W., Schulz-Key H., Soboslay P.T. Determinants for resistance and susceptibility to microfilaraemia in Litomosoides sigmodontis filariasis. Parasitology. 122:2001;641-649.
9. Mahanty S., Nutman T.B. Immunoregulation in human lymphatic filariasis: the role of interleukin 10. Parasite Immunol. 17:1995;385-392.
10. Brattig N., Nietz C., Hounkpatin S., Lucius R., Seeber F., Pichlmeier U., Pogonka T. Differences in cytokine responses to Onchocerca volvulus extract and recombinant Ov33 and OvL3-1 proteins in exposed subjects with various parasitologic and clinical states. J. Infect. Dis. 176:1997;838-842.
11. Doetze A., Satoguina J., Burchard G., Rau T., Löliger C., Fleischer B., Hoerauf A. Antigen-specific cellular hyporesponsiveness in generalized onchocerciasis is mediated by Th3/Tr1- type cytokines IL-10 and TGF-beta but not by a Th1 to Th2 shift. Int. Immunol. 12:2000;623-630.
12. Cooper P.J., Espinel I., Paredes W., Guderian R.H., Nutman T.B. Impaired tetanus-specific cellular and humoral responses following tetanus vaccination in human onchocerciasis: a possible role for interleukin-10. J. Infect. Dis. 178:1998;1133-1138.
13. Henry N.L., Law M., Nutman T.B., Klion A.D. Onchocerciasis in a nonendemic population: clinical and immunologic assessment before treatment and at the time of presumed cure. J. Infect. Dis. 183:2001;512-516.
14. Grogan J.L., Kremsner P.G., Deelder A.M., Yazdanbakhsh M. Antigen-specific proliferation and interferon-gamma and interleukin-5 production are down-regulated during Schistosoma haematobium infection. J. Infect. Dis. 177:1998;1433-1437.
15. Groux H. An overview of regulatory T cells. Microbes Infect. 3:2001;883-889.
16. Groux H., O'Garra A., Bigler M., Rouleau M., Antonenko S., de Vries J.E., Roncarolo M.G. A CD4+ T-cell subset inhibits antigen-specific T-cell responses and prevents colitis. Nature. 389:1997;737-742.
17. Levings M.K., Roncarolo M.G. T-regulatory 1 cells: a novel subset of CD4 T cells with immunoregulatory properties. J. Allergy Clin. Immunol. 106:2000;S109-S112.
18. Groux H., Powrie F. Regulatory T cells and inflammatory bowel disease. Immunol. Today. 20:1999;442-445.
19. Cottrez F., Hurst S.D., Coffman R.L., Groux H. T regulatory cells 1 inhibit a Th2-specific response in vivo. J. Immunol. 165:2000;4848-4853.
20. Yssel H., Lecart S., Pene J. Regulatory T cells and allergic asthma. Microbes Infect. 3:2001;899-904.
21. McGuirk P., McCann C., Mills K.H. Pathogen-specific T regulatory 1 cells induced in the respiratory tract by a bacterial molecule that stimulates interleukin 10 production by dendritic cells: a novel strategy for evasion of protective T helper type 1 responses by Bordetella pertussis. J. Exp. M. 195:2002;221-231.
22. Pannetier C., Even J., Kourilsky P. T-cell repertoire diversity and clonal expansions in normal and clinical samples. Immunol. Today. 16:1995;176-181.
23. Schulz-Key H. The collagenase technique: how to isolate and examine adult Onchocerca volvulus for the evaluation of drug effects. Trop. Med. Parasitol. 39:1988;423-440.
24. Schlotmann T., Waase I., Julch C., Klauenberg U., Muller-Myhsok B., Dietrich M., Fleischer B., Broker B.M. CD4 alphabeta T lymphocytes express high levels of the T lymphocyte antigen CTLA-4 (CD152) in acute malaria. J. Infect. Dis. 182:2000;367-370.
25. Parkhouse R.M., Bofill M., Gomez-Priego A., Janossy G. Human macrophages and T-lymphocyte subsets infiltrating nodules of Onchocerca volvulus. Clin. Exp. Immunol. 62:1985;13-18.
26. Krummel M.F., Allison J.P. CD28 and CTLA-4 have opposing effects on the response of T cells to stimulation. J. Exp. M. 182:1995;459-465.
27. Walunas T.L., Bakker C.Y., Bluestone J.A. CTLA-4 ligation blocks CD28-dependent T cell activation. J. Exp. M. 183:1996;2541-2550.
28. ter Meulen J., Badusche M., Kuhnt K., Doetze A., Satoguina J., Marti T., Loeliger C., Koulemou K., Koivogui L., Schmitz H., Fleischer B., Hoerauf A. Characterization of human CD4(+) T-cell clones recognizing conserved and variable epitopes of the lassa virus nucleoprotein. J. Virol. 74:2000;2186-2192.
29. Rocha B., von Boehmer H. Peripheral selection of the T cell repertoire. Science. 251:1991;1225-1228.
30. Schwartz R.H. T cell clonal anergy. Curr. Opin. Immunol. 9:1997;351-357.
31. Mosmann T.R., Sad S. The expanding universe of T-cell subsets: Th1, Th2 and more. Immunol. Today. 17:1996;138-146.
32. Röcken M., Shevach E.M. Immune deviation-the third dimension of nondeletional T cell tolerance. Immunol. Rev. 149:1996;175-194.
33. Bridoux F., Badou A., Saoudi A., Bernard I., Druet E., Pasquier R., Druet P., Pelletier L. Transforming growth factor beta (TGF-beta)-dependent inhibition of T helper cell 2 (Th2)-induced autoimmunity by self-major histocompatibility complex (MHC) class II-specific, regulatory CD4(+) T cell lines. J. Exp. M. 185:1997;1769-1775.
34. Akdis C.A., Blaser K. Mechanisms of interleukin-10-mediated immune suppression. Immunology. 103:2001;131-136.
35. Akdis C.A., Blesken T., Akdis M., Wuthrich B., Blaser K. Role of interleukin 10 in specific immunotherapy. J. Clin. Invest. 102:1998;98-106.
36. Cook P.J., Davies P., Tunnicliffe W., Ayres J.G., Honeybourne D., Wise R. Chlamydia pneumoniae and asthma. Thorax. 53:1998;254-259.
37. Miyashita N., Kubota Y., Nakajima M., Niki Y., Kawane H., Matsushima T. Chlamydia pneumoniae and exacerbations of asthma in adults. Ann. Allergy Asthma Immunol. 80:1998;405-409.
38. Fukaura H., Kent S.C., Pietrusewicz M.J., Khoury S.J., Weiner H.L., Hafler D.A. Induction of circulating myelin basic protein and proteolipid protein- specific transforming growth factor-beta1-secreting Th3 T cells by oral administration of myelin in multiple sclerosis patients. J. Clin. Invest. 98:1996;70-77.
39. Weiner H.L. Oral tolerance: immune mechanisms and treatment of autoimmune diseases. Immunol. Today. 18:1997;335-343.
40. Akdis C.A., Blaser K. Role of IL-10 in allergen-specific immunotherapy and normal response to allergens. Microbes Infect. 3:2001;891-898.
41. Levings M.K., Sangregorio R., Galbiati F., Squadrone S., de Waal Malefyt R., Roncarolo M.G. IFN-alpha and IL-10 induce the differentiation of human type 1 T regulatory cells. J. Immunol. 166:2001;5530-5539.
42. Schwarz A., Beissert S., Grosse-Heitmeyer K., Gunzer M., Bluestone J.A., Grabbe S., Schwarz T. Evidence for functional relevance of CTLA-4 in ultraviolet-radiation-induced tolerance. J. Immunol. 165:2000;1824-1831.
43. Kitani A., Chua K., Nakamura K., Strober W. Activated self-MHC-reactive T cells have the cytokine phenotype of Th3/T regulatory cell 1 T cells. J. Immunol. 165:2000;691-702.
44. Dieckmann D., Plottner H., Berchtold S., Berger T., Schuler G. Ex vivo isolation and characterization of cd4(+)cd25(+) t cells with regulatory properties from human blood. J. Exp. M. 193:2001;1303-1310.
45. Jonuleit H., Schmitt E., Stassen M., Tuettenberg A., Knop J., Enk A.H. Identification and functional characterization of human cd4(+)cd25(+) t cells with regulatory properties isolated from peripheral blood. J. Exp. M. 193:2001;1285-1294.
46. Levings M.K., Sangregorio R., Roncarolo M.G. Human cd25(+)cd4(+) t regulatory cells suppress naive and memory t cell proliferation and can be expanded in vitro without loss of function. J. Exp. M. 193:2001;1295-1302.
47. Itoh M., Takahashi T., Sakaguchi N., Kuniyasu Y., Shimizu J., Otsuka F., Sakaguchi S. Thymus and autoimmunity: production of CD25+CD4+ naturally anergic and suppressive T cells as a key function of the thymus in maintaining immunologic self-tolerance. J. Immunol. 162:1999;5317-5326.
48. Cooper P.J., Guderian R.H., Nutman T.B., Taylor D.W. Human infection with Onchocerca volvulus does not affect the T helper cell phenotype of the cellular immune response to mycobacterial antigen. Trans. R. Soc. Trop. Med. Hyg. 91:1997;350-352.
49. Cobbold S., Waldmann H. Infectious tolerance. Curr. Opin. Immunol. 10:1998;518-524.
50. Stewart G.R., Boussinesq M., Coulson T., Elson L., Nutman T., Bradley J.E. Onchocerciasis modulates the immune response to mycobacterial antigens. Clin. Exp. Immunol. 117:1999;517-523.
51. Chambers C.A., Krummel M.F., Boitel B., Hurwitz A., Sullivan T.J., Fournier S., Cassell D., Brunner M., Allison J.P. The role of CTLA-4 in the regulation and initiation of T-cell responses. Immunol. Rev. 153:1996;27-46.
52. Doetze A., Erttmann K.D., Gallin M.Y., Fleischer B., Hoerauf A. Production of both IFN-γ and IL-5 by Onchocerca volvulus S1 antigen specific CD4+ T cells from putatively immune individuals. Int. Immunol. 9:1997;721-729.
53. Fehniger T.A., Caligiuri M.A. Interleukin 15: biologyand relevance to human disease. Blood. 97:2001;14-32.